LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth ...

Vertical Aerospace • EVTL-NYSE Buy • $3.39 on March 12 by Canaccord Genuity We are maintaining our Buy rating on shares of ...

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets ...

The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...

STORY HIGHLIGHTS Labcorp agreed to acquire BioReference Health assets for $225 million. The deal includes oncology labs generating $85-$100 million annually. The transaction is expected to close ...

Through this transaction, Labcorp will acquire BioReference Health's laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States.

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...

Labcorp, Opko Health acquire certain assets of BioReference Health Labcorp price target raised to $290 from $260 at Argus Target reports Q4 beat, Walgreens reportedly near go-private deal: Morning ...